Piers Ingram, PhD is the Co-Founder and CEO of Hummingbird Bioscience. After undergraduate studies in applied mathematics, Piers completed his PhD in Systems Biology at Imperial College London funded by the Wellcome Trust Prize Studentship. Piers subsequently held several increasingly senior roles in academia, including as a research group leader at Imperial College, before moving to roles in biopharma R&D and commercial strategy at Sanofi. Seeing the exciting progress in systems biology and immunology over the last decade, Piers decided in 2014 to start Hummingbird Bioscience in order to apply these advances to drug discovery and development. Piers also holds an MBA from INSEAD.